SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $79 million in its first quarter.
On a per-share basis, the San Carlos, California-based company said it had a loss of 19 cents.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 19 cents per share.
The biotechnology company posted revenue of $71.4 million in the period.
For the current quarter ending in June, Iovance Biotherapeutics said it expects revenue in the range of $86 million to $88 million.
The company expects full-year revenue in the range of $350 million to $370 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
